{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:35:37Z","timestamp":1767108937891,"version":"3.37.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"START Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12035-017-0838-2","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T03:54:15Z","timestamp":1514519655000},"page":"6237-6249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination"],"prefix":"10.1007","volume":"55","author":[{"given":"Stefan","family":"Esser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"G\u00f6pfrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Bihler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Kress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Nyamoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone C.","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Clarner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias B.","family":"Stope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Pufe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Kipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-8153","authenticated-orcid":false,"given":"Lars-Ove","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"issue":"5","key":"838_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.2174\/187152712801661248","volume":"11","author":"M Kipp","year":"2012","unstructured":"Kipp M, van der Valk P, Amor S (2012) Pathology of multiple sclerosis. CNS Neurol Disord Drug Targets 11(5):506\u2013517. \nhttps:\/\/doi.org\/10.2174\/187152712801661248","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"838_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/bpa.12454","volume":"27","author":"M Kipp","year":"2017","unstructured":"Kipp M, Nyamoya S, Hochstrasser T, Amor S (2017) Multiple sclerosis animal models: a clinical and histopathological perspective. Brain Pathol 27(2):123\u2013137. \nhttps:\/\/doi.org\/10.1111\/bpa.12454","journal-title":"Brain Pathol"},{"key":"838_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/b978-0-444-52001-2.00002-9","volume":"122","author":"A Kutzelnigg","year":"2014","unstructured":"Kutzelnigg A, Lassmann H (2014) Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb Clin Neurol 122:15\u201358. \nhttps:\/\/doi.org\/10.1016\/b978-0-444-52001-2.00002-9","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"838_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162(1):1\u201311. \nhttps:\/\/doi.org\/10.1111\/j.1365-2249.2010.04143.x","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"838_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/WCO.0b013e32832b4c76","volume":"22","author":"P Valk van der","year":"2009","unstructured":"van der Valk P, Amor S (2009) Preactive lesions in multiple sclerosis. Curr Opin Neurol 22(3):207\u2013213. \nhttps:\/\/doi.org\/10.1097\/WCO.0b013e32832b4c76","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"838_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.20016","volume":"55","author":"MH Barnett","year":"2004","unstructured":"Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55(4):458\u2013468. \nhttps:\/\/doi.org\/10.1002\/ana.20016","journal-title":"Ann Neurol"},{"issue":"9451","key":"838_CR7","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106\u20132112. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet"},{"issue":"3","key":"838_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11910-007-0036-0","volume":"7","author":"H Lassmann","year":"2007","unstructured":"Lassmann H (2007) New concepts on progressive multiple sclerosis. Current neurology and neuroscience reports 7(3):239\u2013244. \nhttps:\/\/doi.org\/10.1007\/s11910-007-0036-0","journal-title":"Current neurology and neuroscience reports"},{"key":"838_CR9","doi-asserted-by":"publisher","first-page":"413465","DOI":"10.1155\/2013\/413465","volume":"2013","author":"NY Hernandez-Pedro","year":"2013","unstructured":"Hernandez-Pedro NY, Espinosa-Ramirez G, de la Cruz VP, Pineda B, Sotelo J (2013) Initial immunopathogenesis of multiple sclerosis: innate immune response. Clin Dev Immunol 2013:413465. \nhttps:\/\/doi.org\/10.1155\/2013\/413465","journal-title":"Clin Dev Immunol"},{"key":"838_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00194","volume":"7","author":"A Barry","year":"2016","unstructured":"Barry A, Cronin O, Ryan AM, Sweeney B, Yap SM, O\u2019Toole O, Allen AP, Clarke G et al (2016) Impact of exercise on innate immunity in multiple sclerosis progression and symptomatology. Front Physiol 7:194. \nhttps:\/\/doi.org\/10.3389\/fphys.2016.00194","journal-title":"Front Physiol"},{"issue":"9","key":"838_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1042\/CS20110164","volume":"121","author":"ML Hanke","year":"2011","unstructured":"Hanke ML, Kielian T (2011) Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci 121(9):367\u2013387. \nhttps:\/\/doi.org\/10.1042\/CS20110164","journal-title":"Clin Sci"},{"issue":"1","key":"838_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2006.04076.x","volume":"99","author":"GW Konat","year":"2006","unstructured":"Konat GW, Kielian T, Marriott I (2006) The role of Toll-like receptors in CNS response to microbial challenge. J Neurochem 99(1):1\u201312. \nhttps:\/\/doi.org\/10.1111\/j.1471-4159.2006.04076.x","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"838_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jneuroim.2012.10.012","volume":"255","author":"LO Brandenburg","year":"2013","unstructured":"Brandenburg LO, Jansen S, Albrecht LJ, Merres J, Gerber J, Pufe T, Tauber SC (2013) CpG oligodeoxynucleotides induce the expression of the antimicrobial peptide cathelicidin in glial cells. J Neuroimmunol 255(1\u20132):18\u201331. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2012.10.012","journal-title":"J Neuroimmunol"},{"issue":"1","key":"838_CR14","first-page":"75","volume":"2","author":"S Miranda-Hernandez","year":"2013","unstructured":"Miranda-Hernandez S, Baxter AG (2013) Role of toll-like receptors in multiple sclerosis. Am J Clin Exp Immunol 2(1):75\u201393","journal-title":"Am J Clin Exp Immunol"},{"key":"838_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jneuroim.2016.12.004","volume":"304","author":"MJ Hossain","year":"2017","unstructured":"Hossain MJ, Tanasescu R, Gran B (2017) Innate immune regulation of autoimmunity in multiple sclerosis: focus on the role of Toll-like receptor 2. J Neuroimmunol 304:11\u201320. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2016.12.004","journal-title":"J Neuroimmunol"},{"issue":"4","key":"838_CR16","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/JCI58644","volume":"122","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM, Brown MA (2012) Innate immunity in the central nervous system. J Clin Invest 122(4):1164\u20131171. \nhttps:\/\/doi.org\/10.1172\/JCI58644","journal-title":"J Clin Invest"},{"issue":"3","key":"838_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/glia.20928","volume":"58","author":"S Lehnardt","year":"2010","unstructured":"Lehnardt S (2010) Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 58(3):253\u2013263. \nhttps:\/\/doi.org\/10.1002\/glia.20928","journal-title":"Glia"},{"issue":"4","key":"838_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11481-009-9170-6","volume":"4","author":"MM Mariani","year":"2009","unstructured":"Mariani MM, Kielian T (2009) Microglia in infectious diseases of the central nervous system. J NeuroImmune Pharmacol 4(4):448\u2013461. \nhttps:\/\/doi.org\/10.1007\/s11481-009-9170-6","journal-title":"J NeuroImmune Pharmacol"},{"issue":"3","key":"838_CR19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1750-3639.2002.tb00445.x","volume":"12","author":"H Zekki","year":"2002","unstructured":"Zekki H, Feinstein DL, Rivest S (2002) The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol 12(3):308\u2013319","journal-title":"Brain Pathol"},{"issue":"9","key":"838_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ni.1775","volume":"10","author":"MF Farez","year":"2009","unstructured":"Farez MF, Quintana FJ, Gandhi R, Izquierdo G, Lucas M, Weiner HL (2009) Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol 10(9):958\u2013964. \nhttps:\/\/doi.org\/10.1038\/ni.1775","journal-title":"Nat Immunol"},{"issue":"6","key":"838_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","volume":"118","author":"M Kipp","year":"2009","unstructured":"Kipp M, Clarner T, Dang J, Copray S, Beyer C (2009) The cuprizone animal model: new insights into an old story. Acta Neuropathol 118(6):723\u2013736. \nhttps:\/\/doi.org\/10.1007\/s00401-009-0591-3","journal-title":"Acta Neuropathol"},{"issue":"12","key":"838_CR22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.14670\/hh-26.1585","volume":"26","author":"T Skripuletz","year":"2011","unstructured":"Skripuletz T, Gudi V, Hackstette D, Stangel M (2011) De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol Histopathol 26(12):1585\u20131597. \nhttps:\/\/doi.org\/10.14670\/hh-26.1585","journal-title":"Histol Histopathol"},{"issue":"12","key":"838_CR23","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/glia.23058","volume":"64","author":"T Draheim","year":"2016","unstructured":"Draheim T, Liessem A, Scheld M, Wilms F, Weissflog M, Denecke B, Kensler TW, Zendedel A et al (2016) Activation of the astrocytic Nrf2\/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model. Glia 64(12):2219\u20132230. \nhttps:\/\/doi.org\/10.1002\/glia.23058","journal-title":"Glia"},{"issue":"3","key":"838_CR24","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s12035-015-9113-6","volume":"53","author":"K Janssen","year":"2016","unstructured":"Janssen K, Rickert M, Clarner T, Beyer C, Kipp M (2016) Absence of CCL2 and CCL3 ameliorates central nervous system grey matter but not white matter demyelination in the presence of an intact blood-brain barrier. Mol Neurobiol 53(3):1551\u20131564. \nhttps:\/\/doi.org\/10.1007\/s12035-015-9113-6","journal-title":"Mol Neurobiol"},{"issue":"7","key":"838_CR25","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1007\/s12035-015-9420-y","volume":"53","author":"R Grosse-Veldmann","year":"2016","unstructured":"Grosse-Veldmann R, Becker B, Amor S, van der Valk P, Beyer C, Kipp M (2016) Lesion expansion in experimental demyelination animal models and multiple sclerosis lesions. Mol Neurobiol 53(7):4905\u20134917. \nhttps:\/\/doi.org\/10.1007\/s12035-015-9420-y","journal-title":"Mol Neurobiol"},{"issue":"1","key":"838_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12031-016-0790-z","volume":"60","author":"N Wagenknecht","year":"2016","unstructured":"Wagenknecht N, Becker B, Scheld M, Beyer C, Clarner T, Hochstrasser T, Kipp M (2016) Thalamus degeneration and inflammation in two distinct multiple sclerosis animal models. J Mol Neurosci 60(1):102\u2013114. \nhttps:\/\/doi.org\/10.1007\/s12031-016-0790-z","journal-title":"J Mol Neurosci"},{"issue":"2","key":"838_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12031-013-0026-4","volume":"51","author":"A Zendedel","year":"2013","unstructured":"Zendedel A, Beyer C, Kipp M (2013) Cuprizone-induced demyelination as a tool to study remyelination and axonal protection. J Mol Neurosci 51(2):567\u2013572. \nhttps:\/\/doi.org\/10.1007\/s12031-013-0026-4","journal-title":"J Mol Neurosci"},{"issue":"4","key":"838_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/86354","volume":"2","author":"C Werts","year":"2001","unstructured":"Werts C, Tapping RI, Mathison JC, Chuang TH, Kravchenko V, Saint Girons I, Haake DA, Godowski PJ et al (2001) Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2(4):346\u2013352. \nhttps:\/\/doi.org\/10.1038\/86354","journal-title":"Nat Immunol"},{"issue":"7","key":"838_CR29","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.4049\/jimmunol.169.7.3480","volume":"169","author":"N Reiling","year":"2002","unstructured":"Reiling N, Holscher C, Fehrenbach A, Kroger S, Kirschning CJ, Goyert S, Ehlers S (2002) Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 169(7):3480\u20133484. \nhttps:\/\/doi.org\/10.4049\/jimmunol.169.7.3480","journal-title":"J Immunol"},{"issue":"1","key":"838_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12031-012-9773-x","volume":"48","author":"JP Buschmann","year":"2012","unstructured":"Buschmann JP, Berger K, Awad H, Clarner T, Beyer C, Kipp M (2012) Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination. J Mol Neurosci 48(1):66\u201376. \nhttps:\/\/doi.org\/10.1007\/s12031-012-9773-x","journal-title":"J Mol Neurosci"},{"issue":"3","key":"838_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12031-010-9419-9","volume":"43","author":"T Clarner","year":"2011","unstructured":"Clarner T, Buschmann JP, Beyer C, Kipp M (2011) Glial amyloid precursor protein expression is restricted to astrocytes in an experimental toxic model of multiple sclerosis. J Mol Neurosci 43(3):268\u2013274. \nhttps:\/\/doi.org\/10.1007\/s12031-010-9419-9","journal-title":"J Mol Neurosci"},{"issue":"10","key":"838_CR32","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/glia.22367","volume":"60","author":"T Clarner","year":"2012","unstructured":"Clarner T, Diederichs F, Berger K, Denecke B, Gan L, van der Valk P, Beyer C, Amor S et al (2012) Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions. Glia 60(10):1468\u20131480. \nhttps:\/\/doi.org\/10.1002\/glia.22367","journal-title":"Glia"},{"issue":"2","key":"838_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12031-015-0595-5","volume":"57","author":"J Goldberg","year":"2015","unstructured":"Goldberg J, Clarner T, Beyer C, Kipp M (2015) Anatomical distribution of cuprizone-induced lesions in C57BL6 mice. J Mol Neurosci 57(2):166\u2013175. \nhttps:\/\/doi.org\/10.1007\/s12031-015-0595-5","journal-title":"J Mol Neurosci"},{"issue":"4","key":"838_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12031-017-0903-3","volume":"61","author":"T Hochstrasser","year":"2017","unstructured":"Hochstrasser T, Exner GL, Nyamoya S, Schmitz C, Kipp M (2017) Cuprizone-containing pellets are less potent to induce consistent demyelination in the corpus callosum of C57BL\/6 mice. J Mol Neurosci 61(4):617\u2013624. \nhttps:\/\/doi.org\/10.1007\/s12031-017-0903-3","journal-title":"J Mol Neurosci"},{"issue":"8","key":"838_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/glia.20806","volume":"57","author":"P Acs","year":"2009","unstructured":"Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A, Berente Z, Komoly S et al (2009) 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 57(8):807\u2013814. \nhttps:\/\/doi.org\/10.1002\/glia.20806","journal-title":"Glia"},{"issue":"2","key":"838_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12031-008-9057-7","volume":"35","author":"M Kipp","year":"2008","unstructured":"Kipp M, Norkute A, Johann S, Lorenz L, Braun A, Hieble A, Gingele S, Pott F et al (2008) Brain-region-specific astroglial responses in vitro after LPS exposure. J Mol Neurosci 35(2):235\u2013243. \nhttps:\/\/doi.org\/10.1007\/s12031-008-9057-7","journal-title":"J Mol Neurosci"},{"issue":"7","key":"838_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2826.2011.02140.x","volume":"23","author":"T Clarner","year":"2011","unstructured":"Clarner T, Parabucki A, Beyer C, Kipp M (2011) Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice. J Neuroendocrinol 23(7):601\u2013611. \nhttps:\/\/doi.org\/10.1111\/j.1365-2826.2011.02140.x","journal-title":"J Neuroendocrinol"},{"issue":"12","key":"838_CR38","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/glia.23202","volume":"65","author":"BJ Ruther","year":"2017","unstructured":"Ruther BJ, Scheld M, Dreymueller D, Clarner T, Kress E, Brandenburg LO, Swartenbroekx T, Hoornaert C et al (2017) Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression. Glia 65(12):1900\u20131913. \nhttps:\/\/doi.org\/10.1002\/glia.23202","journal-title":"Glia"},{"key":"838_CR39","doi-asserted-by":"publisher","unstructured":"Becker B, Demirbas M, Johann S, Zendedel A, Beyer C, Clusmann H, Haas SJ, Wree A et al (2017) Effect of intrastriatal 6-OHDA lesions on extrastriatal brain structures in the mouse. Mol Neurobiol. \nhttps:\/\/doi.org\/10.1007\/s12035-017-0637-9","DOI":"10.1007\/s12035-017-0637-9"},{"issue":"5","key":"838_CR40","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s12035-015-9203-5","volume":"53","author":"A Zendedel","year":"2016","unstructured":"Zendedel A, Johann S, Mehrabi S, Joghataei MT, Hassanzadeh G, Kipp M, Beyer C (2016) Activation and regulation of NLRP3 inflammasome by intrathecal application of SDF-1a in a spinal cord injury model. Mol Neurobiol 53(5):3063\u20133075. \nhttps:\/\/doi.org\/10.1007\/s12035-015-9203-5","journal-title":"Mol Neurobiol"},{"key":"838_CR41","doi-asserted-by":"publisher","first-page":"7678542","DOI":"10.1155\/2016\/7678542","volume":"2016","author":"LJ Albrecht","year":"2016","unstructured":"Albrecht LJ, Tauber SC, Merres J, Kress E, Stope MB, Jansen S, Pufe T, Brandenburg LO (2016) Lack of proinflammatory cytokine Interleukin-6 or tumor necrosis factor receptor-1 results in a failure of the innate immune response after bacterial meningitis. Mediat Inflamm 2016:7678542. \nhttps:\/\/doi.org\/10.1155\/2016\/7678542","journal-title":"Mediat Inflamm"},{"issue":"3","key":"838_CR42","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/imm.12324","volume":"143","author":"S Oldekamp","year":"2014","unstructured":"Oldekamp S, Pscheidl S, Kress E, Soehnlein O, Jansen S, Pufe T, Wang JM, Tauber SC et al (2014) Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis. Immunology 143(3):447\u2013461. \nhttps:\/\/doi.org\/10.1111\/imm.12324","journal-title":"Immunology"},{"issue":"4","key":"838_CR43","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2008.070850","volume":"172","author":"T Skripuletz","year":"2008","unstructured":"Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F, Trebst C, Stangel M (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172(4):1053\u20131061. \nhttps:\/\/doi.org\/10.2353\/ajpath.2008.070850","journal-title":"Am J Pathol"},{"issue":"4","key":"838_CR44","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1523\/JNEUROSCI.2456-15.2016","volume":"36","author":"M Scheld","year":"2016","unstructured":"Scheld M, Ruther BJ, Grosse-Veldmann R, Ohl K, Tenbrock K, Dreymuller D, Fallier-Becker P, Zendedel A et al (2016) Neurodegeneration triggers peripheral immune cell recruitment into the forebrain. J Neurosci 36(4):1410\u20131415. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.2456-15.2016","journal-title":"J Neurosci"},{"issue":"1","key":"838_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jneuroim.2008.06.034","volume":"203","author":"MM Hiremath","year":"2008","unstructured":"Hiremath MM, Chen VS, Suzuki K, Ting JP, Matsushima GK (2008) MHC class II exacerbates demyelination in vivo independently of T cells. J Neuroimmunol 203(1):23\u201332. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.034","journal-title":"J Neuroimmunol"},{"issue":"2","key":"838_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","volume":"32","author":"LA Pasquini","year":"2007","unstructured":"Pasquini LA, Calatayud CA, Bertone Una AL, Millet V, Pasquini JM, Soto EF (2007) The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res 32(2):279\u2013292. \nhttps:\/\/doi.org\/10.1007\/s11064-006-9165-0","journal-title":"Neurochem Res"},{"issue":"5","key":"838_CR47","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2174\/187152712801661284","volume":"11","author":"BJ Star van der","year":"2012","unstructured":"van der Star BJ, Vogel DY, Kipp M, Puentes F, Baker D, Amor S (2012) In vitro and in vivo models of multiple sclerosis. CNS Neurol Disord Drug Targets 11(5):570\u2013588. \nhttps:\/\/doi.org\/10.2174\/187152712801661284","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"7","key":"838_CR48","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.4049\/jimmunol.1401459","volume":"194","author":"T Clarner","year":"2015","unstructured":"Clarner T, Janssen K, Nellessen L, Stangel M, Skripuletz T, Krauspe B, Hess FM, Denecke B et al (2015) CXCL10 triggers early microglial activation in the cuprizone model. J Immunol (Baltimore, Md : 1950) 194(7):3400\u20133413. \nhttps:\/\/doi.org\/10.4049\/jimmunol.1401459","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"Pt 1","key":"838_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/brain\/aws262","volume":"136","author":"T Skripuletz","year":"2013","unstructured":"Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, Voss E, Berger K, Kipp M et al (2013) Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain J Neurol 136(Pt 1):147\u2013167. \nhttps:\/\/doi.org\/10.1093\/brain\/aws262","journal-title":"Brain J Neurol"},{"issue":"25","key":"838_CR50","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1073\/pnas.1006496107","volume":"107","author":"JA Sloane","year":"2010","unstructured":"Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T (2010) Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A 107(25):11555\u201311560. \nhttps:\/\/doi.org\/10.1073\/pnas.1006496107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"838_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1083\/jcb.201206010","volume":"200","author":"Y Sakamoto","year":"2013","unstructured":"Sakamoto Y, Boeda B, Etienne-Manneville S (2013) APC binds intermediate filaments and is required for their reorganization during cell migration. J Cell Biol 200(3):249\u2013258. \nhttps:\/\/doi.org\/10.1083\/jcb.201206010","journal-title":"J Cell Biol"},{"issue":"2","key":"838_CR52","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12031-017-0924-y","volume":"62","author":"K Bihler","year":"2017","unstructured":"Bihler K, Kress E, Esser S, Nyamoya S, Tauber SC, Clarner T, Stope MB, Pufe T et al (2017) Formyl peptide receptor 1-mediated glial cell activation in a mouse model of cuprizone-induced demyelination. J Mol Neurosci 62(2):232\u2013243. \nhttps:\/\/doi.org\/10.1007\/s12031-017-0924-y","journal-title":"J Mol Neurosci"},{"key":"838_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jneuroim.2015.02.005","volume":"280","author":"Y Sun","year":"2015","unstructured":"Sun Y, Chen H, Dai J, Zou H, Gao M, Wu H, Ming B, Lai L et al (2015) HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis. J Neuroimmunol 280:29\u201335. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2015.02.005","journal-title":"J Neuroimmunol"},{"issue":"2","key":"838_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12026-015-8673-x","volume":"64","author":"Z Sternberg","year":"2016","unstructured":"Sternberg Z, Sternberg D, Chichelli T, Drake A, Patel N, Kolb C, Chadha K, Yu J et al (2016) High-mobility group box 1 in multiple sclerosis. Immunol Res 64(2):385\u2013391. \nhttps:\/\/doi.org\/10.1007\/s12026-015-8673-x","journal-title":"Immunol Res"},{"issue":"5","key":"838_CR55","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1189\/jlb.1207844","volume":"84","author":"A Andersson","year":"2008","unstructured":"Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Wallstrom E, Lobell A et al (2008) Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol 84(5):1248\u20131255. \nhttps:\/\/doi.org\/10.1189\/jlb.1207844","journal-title":"J Leukoc Biol"},{"issue":"34","key":"838_CR56","doi-asserted-by":"publisher","first-page":"35131","DOI":"10.18632\/oncotarget.6031","volume":"6","author":"MJ Hossain","year":"2015","unstructured":"Hossain MJ, Tanasescu R, Gran B (2015) TLR2: an innate immune checkpoint in multiple sclerosis. Oncotarget 6(34):35131\u201335132. \nhttps:\/\/doi.org\/10.18632\/oncotarget.6031","journal-title":"Oncotarget"},{"issue":"2","key":"838_CR57","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00401-014-1317-8","volume":"128","author":"M Bsibsi","year":"2014","unstructured":"Bsibsi M, Peferoen LA, Holtman IR, Nacken PJ, Gerritsen WH, Witte ME, van Horssen J, Eggen BJ et al (2014) Demyelination during multiple sclerosis is associated with combined activation of microglia\/macrophages by IFN-gamma and alpha B-crystallin. Acta Neuropathol 128(2):215\u2013229. \nhttps:\/\/doi.org\/10.1007\/s00401-014-1317-8","journal-title":"Acta Neuropathol"},{"key":"838_CR58","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jneuroim.2016.09.003","volume":"299","author":"M Bohland","year":"2016","unstructured":"Bohland M, Kress E, Stope MB, Pufe T, Tauber SC, Brandenburg LO (2016) Lack of Toll-like receptor 2 results in higher mortality of bacterial meningitis by impaired host resistance. J Neuroimmunol 299:90\u201397. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2016.09.003","journal-title":"J Neuroimmunol"},{"issue":"1","key":"838_CR59","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1600-065X.2012.01135.x","volume":"248","author":"L Mayo","year":"2012","unstructured":"Mayo L, Quintana FJ, Weiner HL (2012) The innate immune system in demyelinating disease. Immunol Rev 248(1):170\u2013187. \nhttps:\/\/doi.org\/10.1111\/j.1600-065X.2012.01135.x","journal-title":"Immunol Rev"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-017-0838-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0838-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0838-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T22:30:54Z","timestamp":1532039454000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-017-0838-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1007\/s12035-017-0838-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}